Related Experiment Video
Updated: Oct 27, 2025

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
Chylothorax in a child with rifampicin-resistant tuberculosis
1Department of Paediatrics and Child Health, Faculty of Health Sciences, University of the Witwatersrand, and Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.
Multidrug-resistant tuberculosis (MDR-TB) can cause chylothorax in children, a rare condition. Early consideration of MDR-TB is crucial for children who do not respond to standard tuberculosis treatment.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pulmonology
Background:
- Chylothorax is an uncommon condition in pediatric patients.
- Tuberculosis-associated chylothorax is rarely reported in children.
- Standard TB treatment regimens may not be effective in all pediatric cases.
Observation:
- A child presented with wheezing and chylothorax while undergoing standard four-drug tuberculosis treatment.
- Bronchoscopy revealed caseating lymph nodes.
- Rifampicin-resistant tuberculosis was detected in the bronchoalveolar lavage sample.
Findings:
- The child showed significant clinical and radiological improvement after initiating multidrug-resistant tuberculosis (MDR-TB) treatment and corticosteroids.
- This case highlights a previously undescribed association between chylothorax and MDR-TB in a pediatric patient.
Implications:
- MDR-TB should be suspected in pediatric patients with chylothorax who do not respond to empirical, adherent, drug-susceptible TB therapy.
- This finding expands the known clinical spectrum of MDR-TB in children.
- Prompt diagnosis and appropriate MDR-TB treatment are essential for favorable outcomes.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pneumothorax-II
Clinical Manifestations:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: